RG
Regina Graul, PhD
President and Chief Executive Officer, Member of Board of Directors
Cyclerion TherapeuticsTherapeutic Areas
Cyclerion Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CYC-126 | Treatment-Resistant Depression (TRD) | Phase 2 |
Leadership Team at Cyclerion Therapeutics
RC
Rhonda Chicko
Chief Financial Officer (Consultant)
ED
Errol De Souza, PhD
Chairman of the Board of Directors